US68218J1034 - Common Stock
OABI stock results show that OmniAb missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips OmniAb (NASDAQ:OABI) just reported results for the first quarter of 2024.OmniAb...
OABI stock results show that OmniAb beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips OmniAb (NASDAQ:OABI) just reported results for the fourth quarter of 2023.OmniA...
While you can likely achieve a higher degree of success with blue chips, for blistering gains, turn to powerful small-cap stocks.
OmniAb (OABI) files prospectus for a $300M mixed shelf offering, but it's important to note that this is not an offer to sell securities.
While the concept is incredibly risky, those who want to give their portfolio a jolt should consider these best cheap stocks.
OmniAb shares rise while argenx shares decline after Immunovant posts positive early-stage data for its autoimmune drug candidate, IMVT-1402. Read more here.
OmniAb press release (OABI): Q2 GAAP EPS of -$0.15 misses by $0.04.Revenue of $6.9M misses by $5.01M.As of June 30, 2023, OmniAb had cash, cash equivalents and short-term investments...